Research Study

Randomized Comparative Effectiveness Study of Complete vs Culprit-only Revascularization Strategies to Treat Multi-vessel Disease After Primary Percutaneous Coronary Intervention (PCI) for ST-segment Elevation Myocardial (STEMI) Infarction
Principal Investigator 
David Wood

Overview

Body Locations and Systems 
Heart Attack
Diagnosis and Therapy 
Surgery and Rehabilitation
ClinicalTrials.gov# 
NCT01740479
Status 
Recruiting
Study Start/End 
Jan 1, 2013 to Jan 1, 2019
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Andrew Starovoytov
Phone 
604-875-5079
Purpose of Study 

To determine whether, on a background of optimal medical therapy, including ticagrelor, opening of all suitable narrowings or blockages found at the time of primary PCI for an acute heart attack is better than treating only the culprit lesion in patients with multi-vessel disease.

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.